|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cardiovascular |
-induced rise in [Ca2+]i in rat intrapulmonary arteries
1 Department of Asthma, Allergy and Respiratory Science, King's College London School of Medicine, King's College London, London SE1 1UL, UK
The mechanisms by which prostaglandin F2
(PGF2
) increases intracellular Ca2+ concentration [Ca2+]i in vascular smooth muscle remain unclear. We examined the role of store-, receptor- and voltage-operated Ca2+ influx pathways in rat intrapulmonary arteries (IPA) loaded with Fura PE-3. Low concentrations (0.011 µM) of PGF2
caused a transient followed by a plateau rise in [Ca2+]i. Both responses became maximal at 0.1 µM PGF2
. At higher concentrations of PGF2
, a further slower rise in [Ca2+]i was superimposed on the plateau. The [Ca2+]i response to 0.1 µM PGF2
was mimicked by the FP receptor agonist fluprostenol, whilst the effect of 10 µM PGF2
was mimicked by the TP receptor agonist U-46619. The plateau rise in [Ca2+]i in response to 0.1 µM PGF2
was insensitive to diltiazem, and was abolished in Ca2+-free physiological salt solution, and by pretreatment with La3+, 2-APB, thapsigargin or U-73122. The rises in [Ca2+]i in response to 10 µM PGF2
and 0.01 µM U-46619 were partially inhibited by diltiazem. The diltiazem-resistant components of both of these responses were inhibited by 2-APB and La3+ to an extent which was significantly less than that seen for the response to 0.1 µM PGF2
, and were also much less sensitive to U-73122. The U-46619 response was also relatively insensitive to thapsigargin. When Ca2+ was replaced with Sr2+, the sustained increase in the Fura PE-3 signal to 0.1 µM PGF2
was abolished, whereas 10 µM PGF2
and 0.05 µM U-46619 still caused substantial increases. These results suggest that low concentrations of PGF2
act via FP receptors to cause IP3-dependent Ca2+ release and store operated Ca2+ entry (SOCE). U-46619 and 10100 µM PGF2
cause a TP receptor-mediated Ca2+ influx involving both L-type Ca2+ channels and a receptor operated pathway, which differs from SOCE in its susceptibility to La3+, 2-APB and thapsigargin, does not require phospholipase C activation, and is Sr2+ permeable.
(Received 7 November 2005;
accepted after revision 12 December 2005;
first published online 22 December 2005)
Corresponding author V. Snetkov: Department of Asthma, Allergy and Respiratory Science, New Hunt's House, Guy's Hospital Campus, King's College London, London SE1 1UL, UK. Email: vladimir.snetkov{at}kcl.ac.uk
This article has been cited by other articles:
![]() |
G. A. Knock, Y. Shaifta, V. A. Snetkov, B. Vowles, S. Drndarski, J. P.T. Ward, and P. I. Aaronson Interaction between src family kinases and rho-kinase in agonist-induced Ca2+-sensitization of rat pulmonary artery Cardiovasc Res, February 1, 2008; 77(3): 570 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Snetkov, G. D. Thomas, B. Teague, R. M. Leach, Y. Shaifta, G. A. Knock, P. I. Aaronson, and J. P.T. Ward Low Concentrations of Sphingosylphosphorylcholine Enhance Pulmonary Artery Vasoreactivity: The Role of Protein Kinase C{delta} and Ca2+ Entry Hypertension, February 1, 2008; 51(2): 239 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Moreno, G. Frazziano, A. Cogolludo, L. Cobeno, J. Tamargo, and F. Perez-Vizcaino Role of Protein Kinase C{zeta} and Its Adaptor Protein p62 in Voltage-Gated Potassium Channel Modulation in Pulmonary Arteries Mol. Pharmacol., November 1, 2007; 72(5): 1301 - 1309. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |